Geron Corp. (GERN)

1.47
0.04 2.80
NASDAQ : Health Technology
Prev Close 1.43
Open 1.44
Day Low/High 1.44 / 1.49
52 Wk Low/High 0.95 / 2.14
Volume 792.15K
Avg Volume 1.44M
Exchange NASDAQ
Shares Outstanding 188.42M
Market Cap 280.75M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Commit To Purchase Geron Corp. At $2.50, Earn 18% Using Options

Commit To Purchase Geron Corp. At $2.50, Earn 18% Using Options

Investors eyeing a purchase of Geron Corp. shares, but tentative about paying the going market price of $3.24/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Geron (GERN) Is Strong On High Volume Today

Geron (GERN) Is Strong On High Volume Today

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Cramer awaits this week's earnings from H&R Block, Costco and Adobe Systems, among other companies.

'Mad Money' Lightning Round: Sell Chevron and Royal Dutch Shell

'Mad Money' Lightning Round: Sell Chevron and Royal Dutch Shell

Cramer picks Verizon or AT&T over Frontier Communications and Biogen Idec or Celgene over Geron.

Trade-Ideas: Geron (GERN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Geron (GERN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Geron (GERN) as a weak on high relative volume candidate

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADT, AIN, BDBD, CBS.A, CRAY, EGT, FPRX, GERN, HMPR, ISIL, SCLN Downgrades: ASM, BRS, SRDX Initiations: DPLO, W Read on to get TheStreet Quant Ratings' detailed report:

First Week of GERN June 2016 Options Trading

First Week of GERN June 2016 Options Trading

Investors in Geron Corp. saw new options become available this week, for the June 2016 expiration.

Today's Perilous Reversal Stock: Geron (GERN)

Today's Perilous Reversal Stock: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

Cramer prefers Dominion Resources D to Pepco Holding POM and is sticking with Energy Transfer Partners ETP.

Jim Cramer's 'Mad Money' Recap: The Fed Is Making All the Right Moves

Jim Cramer's 'Mad Money' Recap: The Fed Is Making All the Right Moves

It would have been a huge mistake to raise interest rates, especially since there's no compelling reason to do so, Cramer says.

Strong On High Relative Volume: Geron (GERN)

Strong On High Relative Volume: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

'Fast Money' Recap: Countdown to a Fed Rate Increase

'Fast Money' Recap: Countdown to a Fed Rate Increase

The trading panel discussed why the Federal Reserve should announce a rate hike at its September meeting and wondered if Twitter will ever get a new CEO in place.

Geron (GERN) Showing Signs Of Perilous Reversal Today

Geron (GERN) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Geron (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Dual Publications In The New England Journal Of Medicine Highlight Transformative Potential Of Imetelstat In Hematologic Myeloid Malignancies

Dual Publications In The New England Journal Of Medicine Highlight Transformative Potential Of Imetelstat In Hematologic Myeloid Malignancies

Results From Two Separate Clinical Studies Suggest Disease-Modifying Activity

Interesting GERN Put And Call Options For March 2016

Interesting GERN Put And Call Options For March 2016

Investors in Geron Corp. saw new options become available this week, for the March 2016 expiration.

Geron (GERN) Is Today's Dead Cat Bounce Stock

Geron (GERN) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Geron (GERN) Highlighted As Weak On High Volume

Geron (GERN) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Geron (GERN) as a weak on high relative volume candidate

Strong On High Relative Volume: Geron (GERN)

Strong On High Relative Volume: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Geron (GERN) Strong On High Relative Volume Today

Geron (GERN) Strong On High Relative Volume Today

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Insider Trading Alert - COVS, RRD And GERN Traded By Insiders

Insider Trading Alert - COVS, RRD And GERN Traded By Insiders

Stocks with insider trader activity include COVS, RRD and GERN

TheStreet Quant Rating: D (Sell)